Certificates of Suitability to the monographs of the European Pharmacopoeia
E386103
Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
All labels observed (2)
How this entity was disambiguated
This entity first appeared as the object of triple T3767696 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Certificates of Suitability to the monographs of the European Pharmacopoeia Context triple: [Certificates of Suitability, fullName, Certificates of Suitability to the monographs of the European Pharmacopoeia]
-
A.
Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
-
B.
European Union pharmaceutical legislation
European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
-
C.
ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals is an international regulatory guideline that outlines the nonclinical safety studies needed to support the development and approval of anticancer drugs in humans.
-
D.
World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Certificates of Suitability to the monographs of the European Pharmacopoeia Target entity description: Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
-
A.
Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
-
B.
European Union pharmaceutical legislation
European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
-
C.
ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals is an international regulatory guideline that outlines the nonclinical safety studies needed to support the development and approval of anticancer drugs in humans.
-
D.
World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
EDQM certificate
ⓘ
pharmaceutical quality document ⓘ regulatory certificate ⓘ |
| abbreviation | CEP ⓘ |
| alternativeTo | full active substance master file in some regulatory procedures ⓘ |
| appliesTo |
active pharmaceutical ingredient
ⓘ
excipients ⓘ substances for pharmaceutical use ⓘ |
| basedOn | European Pharmacopoeia ⓘ |
| confirmsComplianceWith |
European Pharmacopoeia
ⓘ
surface form:
European Pharmacopoeia monograph
quality requirements of the European Pharmacopoeia ⓘ |
| contains |
information on impurity profile
ⓘ
information on manufacturing process controls ⓘ information on residual solvents ⓘ information on specific quality attributes required by the monograph ⓘ information on substance quality ⓘ |
| documentType | confidential assessment document for regulators ⓘ |
| effect |
avoids duplication of quality assessment by multiple authorities
ⓘ
facilitates mutual recognition of quality data ⓘ streamlines dossier preparation for manufacturers ⓘ |
| fullName | Certificates of Suitability to the monographs of the European Pharmacopoeia ⓘ |
| governedBy | EDQM certification procedure ⓘ |
| grantedTo | manufacturers of substances for pharmaceutical use ⓘ |
| issuedBy |
European Directorate for the Quality of Medicines & HealthCare
ⓘ
surface form:
EDQM
European Directorate for the Quality of Medicines & HealthCare ⓘ |
| language | issued in official EDQM languages ⓘ |
| purpose |
demonstrate that a substance complies with a European Pharmacopoeia monograph
ⓘ
simplify regulatory approval for medicines in Europe ⓘ support marketing authorisation applications ⓘ |
| recognizedBy |
European medicines regulatory agencies
ⓘ
national competent authorities in Europe ⓘ |
| regulatoryRegion |
Council of Europe member states
ⓘ
European Economic Area ⓘ European Union ⓘ |
| relatedTo |
Council of Europe
ⓘ
European Pharmacopoeia ⓘ
surface form:
European Pharmacopoeia Commission
|
| requires |
assessment of the manufacturer’s quality dossier by EDQM
ⓘ
compliance with relevant general monographs of the European Pharmacopoeia ⓘ compliance with relevant specific monographs of the European Pharmacopoeia ⓘ |
| subjectTo |
possible suspension or withdrawal by EDQM
ⓘ
post-certification surveillance by EDQM ⓘ |
| supports | quality section of medicinal product dossiers ⓘ |
| usedBy |
marketing authorisation holders
ⓘ
pharmaceutical manufacturers ⓘ regulatory authorities in Europe ⓘ |
| usedIn |
marketing authorisation applications for medicinal products
ⓘ
registration dossiers for medicines ⓘ |
| validity | limited period subject to renewal ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Certificates of Suitability to the monographs of the European Pharmacopoeia Description of subject: Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
Certificates of Suitability (CEP)
→
fullName
→
Certificates of Suitability to the monographs of the European Pharmacopoeia
ⓘ
subject surface form:
Certificates of Suitability